Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹174 Cr
Revenue (TTM)
₹788 Cr
Net Profit (TTM)
₹-19 Cr
ROE
-16.6 %
ROCE
1 %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
24.88
EV/EBITDA
13.1
Div. Yield
0 %
Debt to Equity
1
Book Value
₹199.2
EPS
₹35.8
Face value
10
Shares outstanding
23,545,231
CFO
₹890.89 Cr
EBITDA
₹1,158.89 Cr
Net Profit
₹-1,117.06 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bilcare
| 12.5 | -3.9 | -2.4 | 25.5 | 5.8 | 8.0 | 5.3 |
|
BSE Commodities
| 6.1 | 0.2 | 4.5 | -0.8 | 19.7 | 25.6 | -- |
|
BSE Small Cap
| -3.9 | 2.7 | 11.4 | 1.4 | 30.2 | 33.5 | 16.9 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Bilcare
| -18.5 | 108.0 | -54.4 | 89.5 | 116.7 | -41.5 | -46.8 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Commodities
| 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 | -19.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bilcare
|
73.7 | 173.6 | 788.0 | -56.2 | -0.2 | 17.8 | -- | 0.4 |
| 778.0 | 5,040.6 | 2,528.8 | 322.4 | 17.3 | 16.1 | 15.6 | 2.7 | |
| 1,266.2 | 3,317.8 | 2,895.1 | 133.4 | 6.5 | 9.2 | 24.9 | 2.3 | |
| 233.8 | 7,471.9 | 4,213.3 | 361.6 | 11.7 | 15.9 | 20.8 | 3.2 | |
| 1,220.1 | 3,832.2 | 6,885.2 | 357.7 | 3.5 | 5.6 | 18.3 | 1.0 | |
| 177.9 | 655.0 | 591.3 | 26.7 | 5.9 | 11 | 24.6 | 2.6 | |
| 117.1 | 295.4 | 129.2 | 0.2 | 1.1 | 0.2 | -- | 3.4 | |
| 444.5 | 10,089.3 | 5,457.1 | 394.4 | 11.3 | 13.9 | 26 | 3.5 | |
| 589.5 | 4,253.6 | 15,036.1 | 151.6 | 6.5 | 6.8 | 29.9 | 0.6 |
2 min read•By Jatin Khemani
3 min read•By Research Desk
Bilcare Limited provides pharmaceutical packaging research solutions and global clinical services in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging solid dosage... pharmaceutical products; and other packaging films solutions for applications in ID card, specialty film, and food packaging industries. It also provides clinical trial materials supplies and project management services; and nonClonableID, an anti-counterfeiting, security, and brand protection solution for various industry sectors. The company serves pharmaceutical and biotechnology industries. Bilcare Limited was incorporated in 1987 and is based in Pune, India. Read more
Incorporated
1987
Chairman
Shreyans Bhandari
Managing Director
Shreyans Bhandari
Group
Caprihans India - MNC
Headquarters
Pune, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Bilcare Ltd stood at ₹ 1,417 Cr as on 31-Mar-25
The share price of Bilcare Ltd is ₹73.74 (BSE) as of 23-Jun-2025 IST. Bilcare Ltd has given a return of 5.81% in the last 3 years.
Bilcare Ltd has a market capitalisation of ₹ 174 Cr as on 23-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Bilcare Ltd is 0.37 times as on 23-Jun-2025, a 86% discount to its peers’ median range of 2.63 times.
Since, TTM earnings of Bilcare Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Bilcare Ltd and enter the required number of quantities and click on buy to purchase the shares of Bilcare Ltd.
Bilcare Limited provides pharmaceutical packaging research solutions and global clinical services in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging solid dosage pharmaceutical products; and other packaging films solutions for applications in ID card, specialty film, and food packaging industries. It also provides clinical trial materials supplies and project management services; and nonClonableID, an anti-counterfeiting, security, and brand protection solution for various industry sectors. The company serves pharmaceutical and biotechnology industries. Bilcare Limited was incorporated in 1987 and is based in Pune, India.
The promoters of Bilcare Ltd are Mohan Harakchand Bhandari and Nutan Mohan Bhandari. They collectively own 29.99 per cent of the total equity. The chairman of the company is Shreyans Bhandari
The promoters of Bilcare Ltd have pledged 0.42% of the total equity as on Mar-25.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,849
|
|
|
3,821
|
|
|
3,267
|
|
|
659
|
|
|
292
|
|
|
9,849
|
|
|
7,473
|
|
|
5,050
|
|
|
4,228
|
| Bilcare Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
17.83
|
|
Operating margin(%)
|
-0.16
|
|
Net Margin(%)
|
-6.96
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Bilcare Ltd was ₹-19 Cr.
₹-2.11
(
